Chemogenomic screening Identifies the Hsp70 Co-chaperone HDJ2 as a Hub for Anticancer Drug Resistance
Nitika, J. Blackman, L. Knighton, J. Takakuwa, S. K. Calderwood, A. Truman
The paper identifies HDJ2 as a hub for anticancer drug resistance by screening chemical-genetic interactions in cancer cells.
bioRxiv · Oct 28, 2019Cancer Biology